BTC Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.65M Buy
16,933
+393
+2% +$58.9K 0.16% 105
2026
Q1
$2.53M Sell
16,540
-838
-5% -$128K 0.17% 106
2025
Q4
$2.4M Buy
17,378
+99
+0.6% +$13K 0.17% 107
2025
Q3
$2.22M Buy
17,279
+1,528
+10% +$186K 0.15% 111
2025
Q2
$1.91M Buy
15,751
+368
+2% +$41.5K 0.16% 109
2025
Q1
$1.71M Buy
15,383
+473
+3% +$50.4K 0.16% 111
2024
Q4
$1.45M Buy
14,910
+1,608
+12% +$171K 0.13% 111
2024
Q3
$1.53M Buy
13,302
+821
+7% +$93.2K 0.14% 113
2024
Q2
$1.33M Sell
12,481
-420
-3% -$42.2K 0.12% 118
2024
Q1
$1.25M Buy
+12,901
New +$1.32M 0.11% 123
2023
Q3
$1.18M Buy
11,575
+462
+4% +$46.9K 0.14% 122
2023
Q2
$1.12M Sell
11,113
-143
-1% -$14.3K 0.12% 127
2023
Q1
$1.02M Sell
11,256
-934
-8% -$81.6K 0.12% 125
2022
Q4
$1.11M Buy
12,190
+624
+5% +$52.6K 0.13% 124
2022
Q3
$879K Buy
11,566
+893
+8% +$74K 0.11% 128
2022
Q2
$901K Sell
10,673
-10,075
-49% -$884K 0.11% 128
2022
Q1
$1.83M Buy
20,748
+10,065
+94% +$871K 0.18% 115
2021
Q4
$938K Buy
10,683
+568
+6% +$47.2K 0.09% 138
2021
Q3
$827K Buy
10,115
+205
+2% +$18.4K 0.09% 135
2021
Q2
$906K Sell
9,910
-1,832
-16% -$163K 0.1% 124
2021
Q1
$1M Buy
11,742
+678
+6% +$60.8K 0.11% 123
2020
Q4
$1.05M Buy
11,064
+1,197
+12% +$105K 0.12% 118
2020
Q3
$860K Buy
9,867
+3,566
+57% +$309K 0.12% 118
2020
Q2
$550K Buy
+6,301
New +$544K 0.08% 125
2020
Q1
Sell
-4,612
Closed -$434K 177
2019
Q4
$434K Buy
4,612
+1,682
+57% +$151K 0.06% 147
2019
Q3
$255K Sell
2,930
-2,190
-43% -$197K 0.04% 161
2019
Q2
$469K Buy
5,120
+1,878
+58% +$159K 0.08% 139
2019
Q1
$279K Sell
3,242
-150
-4% -$12K 0.04% 158
2018
Q4
$259K Buy
3,392
+419
+14% +$32.6K 0.05% 156
2018
Q3
$229K Sell
2,973
-456
-13% -$33.7K 0.04% 162
2018
Q2
$235K Sell
3,429
-2,559
-43% -$177K 0.06% 135
2018
Q1
$433K Buy
5,988
+204
+4% +$15.5K 0.07% 151
2017
Q4
$434K Buy
5,784
+3,052
+112% +$230K 0.07% 139
2017
Q3
$208K Sell
2,732
-251
-8% -$19K 0.04% 161
2017
Q2
$223K Buy
+2,983
New +$211K 0.04% 161
2016
Q3
Sell
-7,559
Closed -$560K 180
2016
Q2
$560K Buy
7,559
+3,525
+87% +$244K 0.12% 109
2016
Q1
$261K Buy
4,034
+247
+7% +$16.8K 0.06% 130
2015
Q4
$292K Sell
3,787
-1,948
-34% -$155K 0.07% 139
2015
Q3
$475K Buy
+5,735
New +$510K 0.11% 128

Other funds holding NVS

BTC Capital Management's NVS Position: Q2 2026 in Review

BTC Capital Management increased its Novartis (NVS) stake by 2.4% in Q2 2026, buying an estimated $58.9K and bringing the position to 16,933 shares worth $2.65M. The position accounts for 0.16% of the portfolio, ranked #105.

BTC Capital Management first reported a position in NVS in Q3 2015 and has held it in 39 quarters since. 847 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • BTC Capital Management held 16,933 shares of Novartis worth $2.65M as of Q2 2026.
  • BTC Capital Management bought 393 Novartis shares in Q2 2026, an estimated $58.9K.
  • Novartis made up 0.16% of BTC Capital Management's portfolio in Q2 2026, its #105 holding.
  • BTC Capital Management first reported a position in Novartis in Q3 2015 and has held it in 39 quarters since.
  • 847 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on BTC Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.